Birth Asphyxia clinical trials at UC Health
2 research studies open to eligible people

• High-dose Erythropoietin or placebo for birth asphyxia and neonatal encephalopathy

  “Study looking at High-dose Erythropoietin with standard care or placebo with standard of care has better outcomes for infants with HIE”

  open to all eligible people

  Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen to the brain near the time of birth. This results in death or neurologic disabilities including cerebral palsy and cognitive impairment in up to half of affected infants. This clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual therapy) will improve outcomes for infants suffering from HIE.

  at UCSF

• Umbilical Cord Milking in Non-Vigorous Infants

  open to all eligible people

  The investigators will conduct a study of non-vigorous term infants to determine if umbilical cord milking (UCM) results in a lower rate of NICU admissions than early clamping and cutting the umbilical cord at birth for infants who need resuscitation.

  at UC Davis

Last updated: July 16, 2019